| Patent | Date |
|---|
Reversal Agents For Neutralizing The Therapeutic Activity Of Anti-fxia Antibodies
App 20210395390 - WILMEN; Andreas ; et al. | 2021-12-23 |
Epitope of optimized humanized monoclonal antibodies against activated protein C and uses thereof
Grant 11,077,187 - Zhao , et al. August 3, 2 | 2021-08-03 |
Antibodies capable of binding to the coagulation factor XIa and uses thereof
Grant 11,046,783 - Wilmen , et al. June 29, 2 | 2021-06-29 |
Brain Natriuretic Peptide Engrafted Antibodies
App 20210147504 - BROCKSCHNIEDER; Damian ; et al. | 2021-05-20 |
Atrial Natriuretic Peptide Engrafted Antibodies
App 20210139555 - MAYER-BARTSCHMID; Anke ; et al. | 2021-05-13 |
C-type Natriuretic Peptide Engrafted Antibodies
App 20210079056 - BROCKSCHNIEDER; Damian ; et al. | 2021-03-18 |
Antibodies against factor XI and uses thereof
Grant 10,654,941 - Wilmen , et al. | 2020-05-19 |
Antibodies Capable Of Binding To The Coagulation Factor Xia And Uses Thereof
App 20190284300 - WILMEN; Andreas ; et al. | 2019-09-19 |
Novel Antibodies Against Factor Xi And Uses Thereof
App 20190225705 - WILMEN; Andreas ; et al. | 2019-07-25 |
Antibodies capable of binding to the coagulation factor XIa and uses thereof
Grant 10,221,247 - Wilmen , et al. | 2019-03-05 |
Epitope Of Optimized Humanized Monoclonal Antibodies Against Activated Protein C And Uses Thereof
App 20180326053 - ZHAO; Xiao-Yan ; et al. | 2018-11-15 |
Nucleic acids and host cells expressing antibodies capable of binding to the coagulation factor XIa and uses thereof
Grant 10,040,866 - Wilmen , et al. August 7, 2 | 2018-08-07 |
Antibodies Capable Of Binding To The Coagulation Factor Xia And Uses Thereof
App 20180112009 - WILMEN; Andreas ; et al. | 2018-04-26 |
Nucleic Acids And Host Cells Expressing Antibodies Capable Of Binding To The Coagulation Factor Xia And Uses Thereof
App 20180051093 - WILMEN; Andreas ; et al. | 2018-02-22 |
Antibodies capable of binding to the coagulation Factor XI and/or its activated form factor Xia and uses thereof
Grant 9,783,614 - Wilmen , et al. October 10, 2 | 2017-10-10 |
Neutralizing prolactin receptor antibody Mat3 and its therapeutic use
Grant 9,777,063 - Freiberg , et al. October 3, 2 | 2017-10-03 |
Neutralizing prolactin receptor antibodies and their therapeutic use
Grant 9,649,374 - Otto , et al. May 16, 2 | 2017-05-16 |
Neutralizing Prolactin Receptor Antibody Mat3 And Its Therapeutic Use
App 20160319029 - FREIBERG; Christoph ; et al. | 2016-11-03 |
Imidazo-, pyrazolopyrazines and imidazotriazines and their use
Grant 9,434,731 - Siegel , et al. September 6, 2 | 2016-09-06 |
Relaxin fusion polypeptides and uses thereof
Grant 9,382,305 - Wilmen , et al. July 5, 2 | 2016-07-05 |
Neutralizing prolactin receptor antibody Mat3 and its therapeutic use
Grant 9,353,186 - Freiberg , et al. May 31, 2 | 2016-05-31 |
Neutralizing prolactin receptor antibodies and their therapeutic use
Grant 9,241,989 - Otto , et al. January 26, 2 | 2016-01-26 |
Pdgfrbeta-fc Fusion Proteins And Uses Thereof
App 20160009776 - Linden; Lars ; et al. | 2016-01-14 |
Fusion Polypeptides And Uses Thereof
App 20150329613 - WILMEN; Andreas ; et al. | 2015-11-19 |
MONOCLONAL ANTIBODIES AGAINST ACTIVATED PROTEIN C (aPC)
App 20150307625 - ZHAO; Xiao-Yan ; et al. | 2015-10-29 |
Substituted imidazopyrimidines and triazolopyrimidines
Grant 9,051,323 - Siegel , et al. June 9, 2 | 2015-06-09 |
Antibodies capable of binding to the coagulation Factor XI and/or its activated form factor XIa and uses thereof
App 20150099298 - Wilmen; Andreas ; et al. | 2015-04-09 |
Relaxin Fusion Polypeptides And Uses Thereof
App 20140187491 - Wilmen; Andreas ; et al. | 2014-07-03 |
Fusion Proteins Releasing Relaxin And Uses Thereof
App 20140148390 - Haupts; Ulrich ; et al. | 2014-05-29 |
Neutralizing Prolactin Receptor Antibody Mat3 And Its Therapeutic Use
App 20140141003 - Freiberg; Christoph ; et al. | 2014-05-22 |
Substituted pyridines, and use thereof as GSK3 inhibitors
Grant 8,664,246 - Siegel , et al. March 4, 2 | 2014-03-04 |
Substituted Imidazo- And Triazolopyrimidines, Imidazo- And Pyrazolopyrazines And Imidazotriazines
App 20130296343 - SIEGEL; Stephan ; et al. | 2013-11-07 |
Neutralizing Prolactin Receptor Antibodies And Their Therapeutic Use
App 20130272968 - Otto; Christiane ; et al. | 2013-10-17 |
Imidazo-, Pyrazolopyrazines And Imidazotriazines And Their Use
App 20130261115 - SIEGEL; Stephan ; et al. | 2013-10-03 |
Imidazo-, pyrazolopyrazines and imidazotriazines and their use
Grant 8,476,267 - Siegel , et al. July 2, 2 | 2013-07-02 |
Neutralizing Prolactin Receptor Antibodies And Their Therapeutic Use
App 20130129739 - Ottto; Christiane ; et al. | 2013-05-23 |
Substituted imidazo- and triazolopyrimidines, imidazo- and pyrazolopyrazines and imidazotriazines
Grant 8,436,003 - Siegel , et al. May 7, 2 | 2013-05-07 |
Substituted Imidazopyrimidines And Triazolopyrimidines
App 20130040946 - Siegel; Stephan ; et al. | 2013-02-14 |
Neutralizing Prolactin Receptor Antibodies And Their Therapeutic Use
App 20120321632 - Otto; Christiane ; et al. | 2012-12-20 |
Substituted imidazopyrimidines and triazolopyrimidines
Grant 8,273,752 - Siegel , et al. September 25, 2 | 2012-09-25 |
Substituted pyridines, and use thereof as Gsk3 inhibitors
App 20110190316 - Siegel; Stephan ; et al. | 2011-08-04 |
Substituted Imidazo- And Triazolopyrimidines, Imidazo- And Pyrazolopyrazines And Imidazotriazines
App 20110144131 - Siegel; Stephan ; et al. | 2011-06-16 |
Substituted Imidazopyrimidines And Triazolopyrimidines
App 20100113441 - Siegel; Stephan ; et al. | 2010-05-06 |
Inhibition Of Pde2a
App 20100035882 - Ellinghaus; Peter ; et al. | 2010-02-11 |
Triazolotriazines And Triazolopyrazines And Their Use
App 20090258877 - Siegel; Stephan ; et al. | 2009-10-15 |
| 